1. Market Research
  2. > Business Services
  3. > Advertising and Marketing Market Trends
  4. > United States Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Market Research Report

Summary

The United States Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Drugs for Herpes Labialis (Oral Herpes) industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Drugs for Herpes Labialis (Oral Herpes) market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Drugs for Herpes Labialis (Oral Herpes) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 142 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Table Of Contents

United States Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Drugs for Herpes Labialis (Oral Herpes)
1.2 Classification of Drugs for Herpes Labialis (Oral Herpes)
1.3 Applications of Drugs for Herpes Labialis (Oral Herpes)
1.4 Industry Chain Structure of Drugs for Herpes Labialis (Oral Herpes)
1.5 Industry Overview of Drugs for Herpes Labialis (Oral Herpes)
1.6 Industry Policy Analysis of Drugs for Herpes Labialis (Oral Herpes)
1.7 Industry News Analysis of Drugs for Herpes Labialis (Oral Herpes)

2 Manufacturing Cost Structure Analysis of Drugs for Herpes Labialis (Oral Herpes)
2.1 Bill of Materials (BOM) of Drugs for Herpes Labialis (Oral Herpes)
2.2 BOM Price Analysis of Drugs for Herpes Labialis (Oral Herpes)
2.3 Labor Cost Analysis of Drugs for Herpes Labialis (Oral Herpes)
2.4 Depreciation Cost Analysis of Drugs for Herpes Labialis (Oral Herpes)
2.5 Manufacturing Cost Structure Analysis of Drugs for Herpes Labialis (Oral Herpes)
2.6 Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)
2.7 China Price, Cost and Gross of Drugs for Herpes Labialis (Oral Herpes) 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2014

4 Production Analysis of Drugs for Herpes Labialis (Oral Herpes) by Regions, Type, and Applications
4.1 United States Production of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015
4.2 United States Production of Drugs for Herpes Labialis (Oral Herpes) by Type 2010-2015
4.3 United States Sales of Drugs for Herpes Labialis (Oral Herpes) by Applications 2010-2015
4.4 Price Analysis of United States Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015

5 Consumption Volume and Consumption Value Analysis of Drugs for Herpes Labialis (Oral Herpes) by Regions
5.1 United States Consumption Volume of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015
5.2 United States Consumption Value of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015
5.3 United States Consumption Price Analysis of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015

6 Analysis of Drugs for Herpes Labialis (Oral Herpes) Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Drugs for Herpes Labialis (Oral Herpes) 2014-2015
6.3 Sales Overview of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
6.4 Supply, Consumption and Gap of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
6.5 Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015

7 Analysis of Drugs for Herpes Labialis (Oral Herpes) Industry Key Manufacturers
7.1 Beech Tree Labs
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Beech Tree Labs SWOT Analysis

7.2 Foamix Pharmaceuticals
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Foamix Pharmaceuticals SWOT Analysis

7.3 Mymetics Corporation
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Mymetics Corporation SWOT Analysis

7.4 NanoViricides
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 NanoViricides SWOT Analysis

7.5 Onxeo
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Onxeo SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Drugs for Herpes Labialis (Oral Herpes) Product Types
8.5 Market Share Analysis of Different Drugs for Herpes Labialis (Oral Herpes) Price Levels
8.6 Gross Margin Analysis of Different Drugs for Herpes Labialis (Oral Herpes) Applications

9 Marketing Trader or Distributor Analysis of Drugs for Herpes Labialis (Oral Herpes)
9.1 Marketing Channels Status of Drugs for Herpes Labialis (Oral Herpes)
9.2 Traders or Distributors of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Drugs for Herpes Labialis (Oral Herpes)
9.4 United States Import, Export and Trade Analysis of Drugs for Herpes Labialis (Oral Herpes)

10 Development Trend of Drugs for Herpes Labialis (Oral Herpes) Industry 2016-2021
10.1 Capacity and Production Overview of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
10.2 Production Market Share by Product Types of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
10.3 Sales and Sales Revenue Overview of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
10.4 United States Sales of Drugs for Herpes Labialis (Oral Herpes) by Applications 2016-2021
10.5 Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2016-2021

11 Industry Chain Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
11.1 Major Raw Materials Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
11.2 Manufacturing Equipment Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
11.3 Major Players of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
11.4 Key Consumers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
11.5 Supply Chain Relationship Analysis of Drugs for Herpes Labialis (Oral Herpes)

12 New Project Investment Feasibility Analysis of Drugs for Herpes Labialis (Oral Herpes)
12.1 New Project SWOT Analysis of Drugs for Herpes Labialis (Oral Herpes)
12.2 New Project Investment Feasibility Analysis of Drugs for Herpes Labialis (Oral Herpes)

13 Conclusion of the United States Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Drugs for Herpes Labialis (Oral Herpes)
Table Product Specifications of Drugs for Herpes Labialis (Oral Herpes)
Table Classification of Drugs for Herpes Labialis (Oral Herpes)
Figure United States Sales Market Share of Drugs for Herpes Labialis (Oral Herpes) by Product Types in 2014
Table Applications of Drugs for Herpes Labialis (Oral Herpes)
Figure United States Sales Market Share of Drugs for Herpes Labialis (Oral Herpes) by Applications in 2014
Figure Industry Chain Structure of Drugs for Herpes Labialis (Oral Herpes)
Table United States Industry Overview of Drugs for Herpes Labialis (Oral Herpes)
Table Industry Policy of Drugs for Herpes Labialis (Oral Herpes)
Table Industry News List of Drugs for Herpes Labialis (Oral Herpes)
Table Bill of Materials (BOM) of Drugs for Herpes Labialis (Oral Herpes)
Table Bill of Materials (BOM) Price of Drugs for Herpes Labialis (Oral Herpes)
Table Labor Cost of Drugs for Herpes Labialis (Oral Herpes)
Table Depreciation Cost of Drugs for Herpes Labialis (Oral Herpes)
Table Manufacturing Cost Structure Analysis of Drugs for Herpes Labialis (Oral Herpes) in 2014
Figure Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)
Table United States Price Analysis of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (USD/Dose)
Table United States Cost Analysis of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (USD/Dose)
Table United States Gross Analysis of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2014
Table RandD Status and Technology Source of United States Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2014
Table United States Production of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015 (Doses)
Table United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015
Figure United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions in 2014
Figure United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions in 2015
Table United States Production of Drugs for Herpes Labialis (Oral Herpes) by Types in 2010-2015 (Doses)
Table United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2010-2015
Figure United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2014
Figure United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2015
Table United States Sales of Drugs for Herpes Labialis (Oral Herpes) by Applications 2010-2015 (Doses)
Table United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Applications 2010-2015
Figure United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Applications in 2014
Figure United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Applications in 2015
Table Price Comparison of United States Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
Table United States Consumption Volume of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015
Figure United States Consumption Volume Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions in 2014
Figure United States Consumption Volume Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions in 2015
Table United States Consumption Value of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015
Figure United States Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions in 2014
Figure United States Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions in 2015
Table Consumption Price of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (Doses)
Table United States Capacity Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (Doses)
Table United States Production Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (Doses)
Table United States Sales Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers 2010-2015
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
Figure United States Capacity Utilization Rate of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
Figure United States Production Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2014
Figure United States Production Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2015
Figure United States Sales Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2014
Figure United States Sales Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
Table United States Supply, Consumption and Gap of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (Doses)
Table United States Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (Doses)
Table Price of United States Drugs for Herpes Labialis (Oral Herpes) Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Drugs for Herpes Labialis (Oral Herpes) Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD)
Table United States Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015
Table Beech Tree Labs Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Herpes Labialis (Oral Herpes) Picture and Specifications of Beech Tree Labs
Table Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Beech Tree Labs 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses) and Growth Rate of Beech Tree Labs 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Production (Doses) and United States Market Share of Beech Tree Labs 2010-2015
Table Beech Tree Labs Drugs for Herpes Labialis (Oral Herpes) SWOT Analysis
Table Foamix Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Herpes Labialis (Oral Herpes) Picture and Specifications of Foamix Pharmaceuticals
Table Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Foamix Pharmaceuticals 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses) and Growth Rate of Foamix Pharmaceuticals 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Production (Doses) and United States Market Share of Foamix Pharmaceuticals 2010-2015
Table Foamix Pharmaceuticals Drugs for Herpes Labialis (Oral Herpes) SWOT Analysis
Table Mymetics Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Herpes Labialis (Oral Herpes) Picture and Specifications of Mymetics Corporation
Table Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mymetics Corporation 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses) and Growth Rate of Mymetics Corporation 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Production (Doses) and United States Market Share of Mymetics Corporation 2010-2015
Table Mymetics Corporation Drugs for Herpes Labialis (Oral Herpes) SWOT Analysis
Table NanoViricides Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Herpes Labialis (Oral Herpes) Picture and Specifications of NanoViricides
Table Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of NanoViricides 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses) and Growth Rate of NanoViricides 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Production (Doses) and United States Market Share of NanoViricides 2010-2015
Table NanoViricides Drugs for Herpes Labialis (Oral Herpes) SWOT Analysis
Table Onxeo Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Herpes Labialis (Oral Herpes) Picture and Specifications of Onxeo
Table Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Onxeo 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Capacity (Doses), Production (Doses) and Growth Rate of Onxeo 2010-2015
Figure Drugs for Herpes Labialis (Oral Herpes) Production (Doses) and United States Market Share of Onxeo 2010-2015
Table Onxeo Drugs for Herpes Labialis (Oral Herpes) SWOT Analysis
Table Drugs for Herpes Labialis (Oral Herpes) Price by Regions 2010-2015
Table Drugs for Herpes Labialis (Oral Herpes) Price by Product Types 2010-2015
Table Drugs for Herpes Labialis (Oral Herpes) Price by Companies 2010-2015
Table Drugs for Herpes Labialis (Oral Herpes) Gross Margin by Companies 2010-2015
Table Price Comparison of Drugs for Herpes Labialis (Oral Herpes) by Regions 2010-2015 (USD/Dose)
Table Price of Different Drugs for Herpes Labialis (Oral Herpes) Product Types (USD/Dose)
Table Market Share of Different Drugs for Herpes Labialis (Oral Herpes) Price Level
Table Gross Margin of Different Drugs for Herpes Labialis (Oral Herpes) Applications
Table Marketing Channels Status of Drugs for Herpes Labialis (Oral Herpes)
Table Traders or Distributors of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Drugs for Herpes Labialis (Oral Herpes) (USD/Dose) in 2015
Table United States Import, Export, and Trade of Drugs for Herpes Labialis (Oral Herpes) (Doses)
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
Figure United States Capacity Utilization Rate of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
Table United States Drugs for Herpes Labialis (Oral Herpes) Production by Type 2016-2021 (Doses)
Table United States Drugs for Herpes Labialis (Oral Herpes) Production Market Share by Type 2016-2021
Figure United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2021
Figure United States Sales (Doses) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
Figure United States Sales of Drugs for Herpes Labialis (Oral Herpes) by Applications 2016-2021 (Doses)
Table United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Applications 2016-2021
Figure United States Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Applications in 2021
Table United States Production, Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 (Doses)
Table United States Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2016-2021
Table Major Raw Materials Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
Table Manufacturing Equipment Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
Table Major Players of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
Table Key Consumers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information
Table Supply Chain Relationship Analysis of Drugs for Herpes Labialis (Oral Herpes)
Table New Project SWOT Analysis of Drugs for Herpes Labialis (Oral Herpes)
Table New Project Investment Feasibility Analysis of Drugs for Herpes Labialis (Oral Herpes)
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
IDC PlanScape: Cognitive/Artificial Intelligence in  Retail Marketing

IDC PlanScape: Cognitive/Artificial Intelligence in Retail Marketing

  • $ 4500
  • Industry report
  • September 2016
  • by IDC

This IDC study examines the application of cognitive software and artificial intelligence in marketing to improve top-line results, campaign performance, customer loyalty, omni-channel outcomes, knowledge ...

IDC FutureScape: Worldwide CMO 2017 Predictions

IDC FutureScape: Worldwide CMO 2017 Predictions

  • $ 4500
  • Industry report
  • November 2016
  • by IDC

This IDC study provides IDC's top 10 predictions for chief marketing officers and their organizations for 2017. The predictions in this document detail how 10 powerfully disruptive forces can be used to ...

World Online Advertising Market, IDATE

World Online Advertising Market, IDATE

  • $ 4600
  • Industry report
  • September 2016
  • by IDATE

Programmatic - RTB - Search - Display - Mobile - Social networking – Video Markets at December 2015 & Forecasts to 2020 The World Online Advertising market package includes: - a database with quantitative ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.